• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经免疫系统是阿片类物质使用障碍的治疗靶点吗?一项系统综述。

Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review.

作者信息

Toloff Katelyn, Woodcock Eric A

机构信息

Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, USA.

出版信息

Med Res Arch. 2022 Aug;10(8). doi: 10.18103/mra.v10i8.2955.

DOI:10.18103/mra.v10i8.2955
PMID:37744743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516332/
Abstract

Opioid use disorder (OUD) is an epidemic in the United States. In the past 12 months alone, there have been 75,000+ deaths attributed to opioid overdose: more than any other year in American history. Current pharmacotherapies for the treatment of OUD effectively suppress opioid withdrawal symptoms, but long-term relapse rates remain unacceptably high. Novel treatments for OUD are desperately needed to curb this epidemic. One target that has received considerable recent interest is the neuroimmune system. The neuroimmune system is anchored by glial cells, i.e., microglia and astrocytes, but neuroimmune signaling is known to influence neurons, including altering neurotransmission, synapse formation, and ultimately, brain function. Preclinical studies have shown that experimental attenuation of pro-inflammatory neuroimmune signaling modulates opioid addiction processes, including opioid reward, tolerance, and withdrawal symptoms, which suggests potential therapeutic benefit in patients. Whereas the peripheral immune system in OUD patients has been studied for decades and is well-understood, little is known about the immune system in OUD patients or its viability as a treatment target. Herein, we review the literature describing relationships between opioid administration and the neuroimmune system, the influence of neuroimmune signaling on opioid addiction processes, and the therapeutic potential for targeting the neuroimmune system in OUD subjects using glial modulator medications.

摘要

阿片类药物使用障碍(OUD)在美国呈泛滥之势。仅在过去12个月里,就有超过7.5万人死于阿片类药物过量:这一数字超过了美国历史上的任何一年。目前用于治疗OUD的药物疗法能有效抑制阿片类药物戒断症状,但长期复发率仍高得令人难以接受。迫切需要新的OUD治疗方法来遏制这一泛滥情况。最近备受关注的一个靶点是神经免疫系统。神经免疫系统以神经胶质细胞为基础,即小胶质细胞和星形胶质细胞,但已知神经免疫信号会影响神经元,包括改变神经传递、突触形成,并最终影响脑功能。临床前研究表明,促炎性神经免疫信号的实验性减弱可调节阿片类药物成瘾过程,包括阿片类药物奖赏、耐受性和戒断症状,这表明对患者可能具有治疗益处。尽管对OUD患者的外周免疫系统已研究了数十年且已被充分了解,但对OUD患者的免疫系统及其作为治疗靶点的可行性却知之甚少。在此,我们综述了描述阿片类药物给药与神经免疫系统之间关系、神经免疫信号对阿片类药物成瘾过程的影响以及使用神经胶质调节剂药物靶向OUD患者神经免疫系统的治疗潜力的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/d35441604f5d/nihms-1881237-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/1562dacb5ebe/nihms-1881237-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/32192a0b479f/nihms-1881237-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/d35441604f5d/nihms-1881237-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/1562dacb5ebe/nihms-1881237-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/32192a0b479f/nihms-1881237-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9edd/10516332/d35441604f5d/nihms-1881237-f0003.jpg

相似文献

1
Is the Neuroimmune System a Therapeutic Target for Opioid Use Disorder? A Systematic Review.神经免疫系统是阿片类物质使用障碍的治疗靶点吗?一项系统综述。
Med Res Arch. 2022 Aug;10(8). doi: 10.18103/mra.v10i8.2955.
2
Neuroimmune Mechanisms of Opioid Use Disorder and Recovery: Translatability to Human Studies, and Future Research Directions.阿片类物质使用障碍和康复的神经免疫机制:向人类研究的可转移性,以及未来的研究方向。
Neuroscience. 2023 Sep 15;528:102-116. doi: 10.1016/j.neuroscience.2023.07.031. Epub 2023 Aug 9.
3
Glial neuroimmune signaling in opioid reward.胶质细胞神经免疫信号在阿片类药物奖赏中的作用。
Brain Res Bull. 2020 Feb;155:102-111. doi: 10.1016/j.brainresbull.2019.11.012. Epub 2019 Nov 29.
4
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder.超越阿片受体:对治疗阿片类药物使用障碍的新疗法的迫切需求。
J Neurol Sci. 2022 Jan 15;432:120094. doi: 10.1016/j.jns.2021.120094. Epub 2021 Dec 16.
5
Modeling the Dynamics of Heroin and Illicit Opioid Use Disorder, Treatment, and Recovery.建模海洛因和非法阿片类药物使用障碍、治疗和康复的动态。
Bull Math Biol. 2022 Mar 2;84(4):48. doi: 10.1007/s11538-022-01002-w.
6
Opioid use disorder: current trends and potential treatments.阿片类药物使用障碍:当前趋势和潜在治疗方法。
Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. eCollection 2023.
7
Emerging Evidence for Cannabis' Role in Opioid Use Disorder.大麻在阿片类物质使用障碍中作用的新证据。
Cannabis Cannabinoid Res. 2018 Sep 1;3(1):179-189. doi: 10.1089/can.2018.0022. eCollection 2018.
8
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update.成人阿片类药物依赖治疗的现有和新兴药物治疗方法:全面更新。
Expert Opin Pharmacother. 2022 Nov;23(16):1819-1830. doi: 10.1080/14656566.2022.2140039. Epub 2022 Nov 14.
9
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.阿片类药物戒断症状是慢性阿片类药物使用和阿片类药物使用障碍的后果:目前的认识和管理方法。
J Clin Pharm Ther. 2020 Oct;45(5):892-903. doi: 10.1111/jcpt.13114. Epub 2020 Jan 27.
10
The dynamics of heroin and illicit opioid use disorder, casual use, treatment, and recovery: A mathematical modeling analysis.海洛因和非法阿片类药物使用障碍、偶尔使用、治疗及康复的动态变化:一项数学建模分析。
Math Biosci Eng. 2024 Feb 1;21(2):3165-3206. doi: 10.3934/mbe.2024141.

本文引用的文献

1
Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.阿尔茨海默病中转位蛋白(TSPO)的神经炎症 PET 成像:最新进展。
Eur J Neurosci. 2022 Mar;55(5):1322-1343. doi: 10.1111/ejn.15613. Epub 2022 Feb 10.
2
Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder.背外侧前额叶皮层和伏隔核的转录改变与阿片类药物使用障碍中的神经炎症和突触重塑有关。
Biol Psychiatry. 2021 Oct 15;90(8):550-562. doi: 10.1016/j.biopsych.2021.06.007. Epub 2021 Jun 12.
3
Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.
米诺环素可减轻非依赖型、 recreational 类阿片使用者体内羟考酮诱导的阳性主观反应。
Pharmacol Biochem Behav. 2021 Oct;209:173241. doi: 10.1016/j.pbb.2021.173241. Epub 2021 Jul 21.
4
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial.米诺环素增强治疗抵抗性抑郁症伴低度外周炎症患者的疗效:一项双盲随机临床试验结果。
Neuropsychopharmacology. 2021 Apr;46(5):939-948. doi: 10.1038/s41386-020-00948-6. Epub 2021 Jan 28.
5
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.神经退行性疾病中的神经炎症:小胶质细胞和星形胶质细胞的作用。
Transl Neurodegener. 2020 Nov 26;9(1):42. doi: 10.1186/s40035-020-00221-2.
6
Opioid-induced structural and functional plasticity of medium-spiny neurons in the nucleus accumbens.阿肯伯氏核中中刺神经元的阿片类药物诱导的结构和功能可塑性。
Neurosci Biobehav Rev. 2021 Jan;120:417-430. doi: 10.1016/j.neubiorev.2020.10.015. Epub 2020 Nov 2.
7
Ibudilast, a Phosphodiesterase Inhibitor and Toll-Like Receptor-4 Antagonist, Improves Hemorrhagic Shock and Reperfusion-Induced Left Ventricular Dysfunction by Reducing Myocardial Tumor Necrosis Factor α.异丁司特,一种磷酸二酯酶抑制剂和Toll样受体4拮抗剂,通过降低心肌肿瘤坏死因子α改善失血性休克和再灌注诱导的左心室功能障碍。
Transplant Proc. 2020 Jul-Aug;52(6):1869-1874. doi: 10.1016/j.transproceed.2020.02.145. Epub 2020 Jul 4.
8
Quantification of [C]PBR28 data after systemic lipopolysaccharide challenge.全身脂多糖攻击后[C]PBR28数据的定量分析。
EJNMMI Res. 2020 Mar 12;10(1):19. doi: 10.1186/s13550-020-0605-7.
9
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.丁丙诺啡的叙述性药理学综述:一种用于治疗慢性疼痛的独特阿片类药物。
Pain Ther. 2020 Jun;9(1):41-54. doi: 10.1007/s40122-019-00143-6. Epub 2020 Jan 28.
10
The Role of Opioid Receptors in Immune System Function.阿片受体在免疫系统功能中的作用。
Front Immunol. 2019 Dec 20;10:2904. doi: 10.3389/fimmu.2019.02904. eCollection 2019.